Kerendia is indicated for the treatment of chronic kidney disease (Stages 3 and 4 with albuminuria) associated with type 2 diabetes in adult patients.
Kerendia®▼ (finerenone) Specialists’ Resources
Fidelio- DKD Infographic
A visual overview of the Fidelio-DKD trial which demonstrated how Kerendia delayed CKD progression in adults with CKD associated with T2D vs placebo
Dosing guide for Kerendia
This dosing card provides details on initiating treatment with Kerendia, dose adjustment and monitoring requirements.
CKD & T2D - Practical Guide
Support with optimising the management of patients who have Chronic Kidney Disease (CKD) associated with Type 2 Diabetes (T2D).
Hyperkalaemia management
Practical guide to the management of hyperkalaemia
England and Wales Formulary
This information pack may support you with your formulary application in England or Wales.
Scotland Formulary
This information pack my support you with your formulary application in Scotland.
RP-KER-GB-1105 | January 2025